Report Detail
Global Antibody Drug Conjugates Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4530805 |
- 16 May, 2023 |
- Global |
- 100 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Antibody Drug Conjugates Contract Manufacturing market size was valued at USD 2909.1 million in 2022 and is forecast to a readjusted size of USD 9320.3 million by 2029 with a CAGR of 18.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key global companies of Antibody Drug Conjugates Contract Manufacturing (ADC) include Lonza, Merck, Recipharm, Thermo Fisher, AbbVie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions and Curia. The top three players are Lonza, Merck and Recipharm, which together account for about 50% of the global market share. The largest player is Lonza Group. From the production side, the global players are mainly concentrated in North America and Europe. North America accounts for about 35% of the global market share. In terms of type, IgG1 dominates the global antibody drug conjugate contract manufacturing market. In terms of application, solid tumor applications account for more than half of the market.
ADCs are mainly composed of three parts: antibodies, linkers, and cytotoxic loads. They are a type of bioactive cytotoxic drugs that are linked to monoclonal antibodies through chemical bonds and use monoclonal antibodies as carriers to target and transport cytotoxic drugs to target cells. Complex that works. The design concept of ADC was first proposed by Paul Ehrlich in the early 20th century. In 2000, the U.S. Food and Drug Administration (FDA) approved the first ADC drug, Mylotarg® (gemtuzumab ozogamicin), for the treatment of acute myeloid myelopathy in adults. Leukemic cell lines, marking the beginning of the era of ADC-targeted cancer therapy.
This report is a detailed and comprehensive analysis for global Antibody Drug Conjugates Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antibody Drug Conjugates Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antibody Drug Conjugates Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antibody Drug Conjugates Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antibody Drug Conjugates Contract Manufacturing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody Drug Conjugates Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody Drug Conjugates Contract Manufacturing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific and Abbvie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Antibody Drug Conjugates Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
IgG1
IgG4
Market segment by Application
Solid Tumors
Hematological Malignancies
Market segment by players, this report covers
Lonza Group
Merck KGaA
Recipharm
Thermo Fisher Scientific
Abbvie
Piramal Pharma Solutions
Catalent
Sterling Pharma Solutions
Curia
Novasep
Ajinomoto Bio-Pharma Services
BSP Pharmaceuticals
Cerbios-Pharma
Goodwin Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Drug Conjugates Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Drug Conjugates Contract Manufacturing, with revenue, gross margin and global market share of Antibody Drug Conjugates Contract Manufacturing from 2018 to 2023.
Chapter 3, the Antibody Drug Conjugates Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antibody Drug Conjugates Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Drug Conjugates Contract Manufacturing.
Chapter 13, to describe Antibody Drug Conjugates Contract Manufacturing research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Antibody Drug Conjugates Contract Manufacturing
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Antibody Drug Conjugates Contract Manufacturing by Type
- 1.3.1 Overview: Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type in 2022
- 1.3.3 IgG1
- 1.3.4 IgG4
- 1.4 Global Antibody Drug Conjugates Contract Manufacturing Market by Application
- 1.4.1 Overview: Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Solid Tumors
- 1.4.3 Hematological Malignancies
- 1.5 Global Antibody Drug Conjugates Contract Manufacturing Market Size & Forecast
- 1.6 Global Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast by Region
- 1.6.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region, (2018-2029)
- 1.6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)
- 1.6.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)
- 1.6.6 South America Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Lonza Group
- 2.1.1 Lonza Group Details
- 2.1.2 Lonza Group Major Business
- 2.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.1.4 Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Lonza Group Recent Developments and Future Plans
- 2.2 Merck KGaA
- 2.2.1 Merck KGaA Details
- 2.2.2 Merck KGaA Major Business
- 2.2.3 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.2.4 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Merck KGaA Recent Developments and Future Plans
- 2.3 Recipharm
- 2.3.1 Recipharm Details
- 2.3.2 Recipharm Major Business
- 2.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.3.4 Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Recipharm Recent Developments and Future Plans
- 2.4 Thermo Fisher Scientific
- 2.4.1 Thermo Fisher Scientific Details
- 2.4.2 Thermo Fisher Scientific Major Business
- 2.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.4.4 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
- 2.5 Abbvie
- 2.5.1 Abbvie Details
- 2.5.2 Abbvie Major Business
- 2.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.5.4 Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Abbvie Recent Developments and Future Plans
- 2.6 Piramal Pharma Solutions
- 2.6.1 Piramal Pharma Solutions Details
- 2.6.2 Piramal Pharma Solutions Major Business
- 2.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.6.4 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Piramal Pharma Solutions Recent Developments and Future Plans
- 2.7 Catalent
- 2.7.1 Catalent Details
- 2.7.2 Catalent Major Business
- 2.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.7.4 Catalent Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Catalent Recent Developments and Future Plans
- 2.8 Sterling Pharma Solutions
- 2.8.1 Sterling Pharma Solutions Details
- 2.8.2 Sterling Pharma Solutions Major Business
- 2.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.8.4 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Sterling Pharma Solutions Recent Developments and Future Plans
- 2.9 Curia
- 2.9.1 Curia Details
- 2.9.2 Curia Major Business
- 2.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.9.4 Curia Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Curia Recent Developments and Future Plans
- 2.10 Novasep
- 2.10.1 Novasep Details
- 2.10.2 Novasep Major Business
- 2.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.10.4 Novasep Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Novasep Recent Developments and Future Plans
- 2.11 Ajinomoto Bio-Pharma Services
- 2.11.1 Ajinomoto Bio-Pharma Services Details
- 2.11.2 Ajinomoto Bio-Pharma Services Major Business
- 2.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.11.4 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
- 2.12 BSP Pharmaceuticals
- 2.12.1 BSP Pharmaceuticals Details
- 2.12.2 BSP Pharmaceuticals Major Business
- 2.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.12.4 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 BSP Pharmaceuticals Recent Developments and Future Plans
- 2.13 Cerbios-Pharma
- 2.13.1 Cerbios-Pharma Details
- 2.13.2 Cerbios-Pharma Major Business
- 2.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.13.4 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Cerbios-Pharma Recent Developments and Future Plans
- 2.14 Goodwin Biotechnology
- 2.14.1 Goodwin Biotechnology Details
- 2.14.2 Goodwin Biotechnology Major Business
- 2.14.3 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product and Solutions
- 2.14.4 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
- 2.14.5 Goodwin Biotechnology Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Antibody Drug Conjugates Contract Manufacturing Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Antibody Drug Conjugates Contract Manufacturing by Company Revenue
- 3.2.2 Top 3 Antibody Drug Conjugates Contract Manufacturing Players Market Share in 2022
- 3.2.3 Top 6 Antibody Drug Conjugates Contract Manufacturing Players Market Share in 2022
- 3.3 Antibody Drug Conjugates Contract Manufacturing Market: Overall Company Footprint Analysis
- 3.3.1 Antibody Drug Conjugates Contract Manufacturing Market: Region Footprint
- 3.3.2 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Type Footprint
- 3.3.3 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Antibody Drug Conjugates Contract Manufacturing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Antibody Drug Conjugates Contract Manufacturing Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
- 6.2 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
- 6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
- 6.3.1 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2029)
- 6.3.2 United States Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 6.3.3 Canada Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
- 7.2 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
- 7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country
- 7.3.1 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2029)
- 7.3.2 Germany Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 7.3.3 France Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 7.3.5 Russia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 7.3.6 Italy Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region
- 8.3.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2018-2029)
- 8.3.2 China Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 8.3.3 Japan Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 8.3.5 India Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 8.3.7 Australia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
- 9.2 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
- 9.3 South America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
- 9.3.1 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country
- 10.3.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
- 10.3.4 UAE Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Antibody Drug Conjugates Contract Manufacturing Market Drivers
- 11.2 Antibody Drug Conjugates Contract Manufacturing Market Restraints
- 11.3 Antibody Drug Conjugates Contract Manufacturing Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Antibody Drug Conjugates Contract Manufacturing Industry Chain
- 12.2 Antibody Drug Conjugates Contract Manufacturing Upstream Analysis
- 12.3 Antibody Drug Conjugates Contract Manufacturing Midstream Analysis
- 12.4 Antibody Drug Conjugates Contract Manufacturing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Antibody Drug Conjugates Contract Manufacturing. Industry analysis & Market Report on Antibody Drug Conjugates Contract Manufacturing is a syndicated market report, published as Global Antibody Drug Conjugates Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Antibody Drug Conjugates Contract Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
